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Abstract 
D2 and D4 dopamine receptors play an important role in cognitive functions in the 
prefrontal cortex and they are involved in the pathophysiology of neuropsychiatric 
disorders such as schizophrenia. The eventual effect of dopamine upon pyramidal 
neurons in the prefrontal cortex depends on which receptors are expressed in the 
different neuronal populations. Parvalbumin and calbindin mark two subpopulations of 
cortical GABAergic interneurons that differently innervate pyramidal cells. Recent 
hypotheses about schizophrenia hold that the root of the illness is a dysfunction of 
parvalbumin chandelier cells that produces disinhibition of pyramidal cells. In the 
present work we report double in situ hybridization histochemistry experiments to 
determine the prevalence of D2 receptor mRNA and D4 receptor mRNA in 
glutamatergic neurons, GABAergic interneurons and both parvalbumin and calbindin 
GABAergic subpopulations in monkey prefrontal cortex layer V. We found that around 
54% of glutamatergic neurons express D2 mRNA and 75% express D4 mRNA, while 
GAD-positive interneurons express around 34% and 47% respectively. Parvalbumin 
cells mainly expressed D4 mRNA (65%) and less D2 mRNA (15-20%). Finally, 
calbindin cells expressed both receptors in similar proportions (37%). We hypothesized 
that D4 receptor could be a complementary target in designing new antipsychotics, 
mainly because of its predominance in parvalbumin interneurons. 
 
Keywords: calbindin, co-localization, glutamatergic neurons, in situ hybridization, 
parvalbumin. 
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Dopaminergic afferents in the prefrontal cortex (PFC) play an important role in 
normal cognitive functions and neuropsychiatric pathophysiology (Seeman et al., 1995; 
Williams and Goldman-Rakic, 1995). Dopaminergic inputs regulate different aspects of 
working memory, planning, attention, and malfunction could help explain some 
positive, negative and cognitive symptoms observed in schizophrenia. 
The majority of studies into the etiology and treatment of schizophrenia focus on 
dopamine D2 receptors, due to the affinity most antipsychotic drugs show for them. 
However, some antipsychotics such as clozapine show a high affinity for D4 receptors 
(Van Tol et al., 1991; Kapur and Remington, 2001). Furthermore, D4 receptors are 
predominant in monkey PFC (Lidow et al., 1998; Mulcrone and Kerwin, 1997; Staley et 
al., 2000). Taken together, this could mean that part of the therapeutic effect of some 
antipsychotics attributed to D2 receptors could be due to the action of these drugs on D4 
receptors (Seeman et al., 1997; Kapur and Remington, 2001).  
Dopaminergic axons innervate PFC pyramidal neurons and GABAergic interneurons 
(Goldman-Rakic et al., 1989; 1998; Sesack et al., 1995), and D2-like receptors are 
present in both populations (Vincent et al., 1993; Khan et al., 1998; Santana et al., 2009; 
Mrzljak et al., 1996; Wedzony et al., 2000). However, there is no precise and accurate 
quantification of dopamine receptors in PFC cellular populations in primates.  
There are several types of GABAergic neurons in the PFC. Two important 
subpopulations are those that express parvalbumin (PV) and those that express calbindin 
(CB). The former have the morphology of chandelier cells or large basket cells, while 
the majority of the latter have the morphology of double-bouquet cells (Conde et al., 
1994; DeFelipe, 1997; Zaitsev et al., 2005). Changes in these cell populations have been 
described in schizophrenia, (Daviss and Lewis, 1995; Hashimoto et al., 2003; Beasley et 
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al., 2002), bipolar disorder (Sakai et al., 2008) and major depressive disorder 
(Rajkowska et al., 2007). Recent hypotheses about the pathophysiology of 
schizophrenia maintain that there is a dysfunction of PV+ chandelier cells that results in 
a disinhibition of pyramidal cells. The functional deficit of PV+ interneurons could 
produce hyperactivity in basal conditions, saturating the capacity of pyramidal neurons, 
preventing normal PFC and hippocampus recruitment during cognitive tasks, and this 
could contribute to working memory dysfunction in subjects with schizophrenia (Lewis 
et al., 2005). This suggest that the main effect of most antipsychotics is the inhibition of 
the inhibitory activity of D2-like receptors localized in PV+ GABAergic interneurons, 
which increases their excitability and consequently reduces pyramidal neuron 
hyperactivity (Lewis and Gonzalez-Burgos, 2006; Lisman et al., 2008).  
Our aim in the present work is to contribute to the study of the cellular localization 
and distribution of both D2 and D4 receptor mRNA in identified neuronal populations 
of monkey PFC. To this end we use dual-label in situ hybridization histochemistry with 
specific oligonucleotides for these receptors and for the cellular markers. We quantify 
the proportion of glutamatergic and of GABAergic neurons (as well as PV+ and CB+ 
GABAergic subpopulations) that express D2 and D4 dopamine receptors in monkey 
PFC.  
 
Materials and Methods 
Specimens and tissue preparation 
Three monkey brains (Macaca fascicularis, aged 2 years and 2 months) were used. 
The animals were administered an overdose of sodium pentobarbital (60 mg/kg, i.v.). 
All procedures followed European Union regulations (O.J. of E.C. L358/1 18/12/1986). 
Upon removal of the brain from the skull, tissue blocks about 1 cm thick were dissected, 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
6 
 
immediately frozen and kept at - 20ºC until used. Coronal tissue sections 20 m thick 
were cut from the frozen blocks using a microtome-cryostat (Microm HM500 OM, 
Walldorf, Germany), thaw-mounted on slides coated with APTS (3-
aminopropyltriethoxysilane, Sigma, St Louis, MO, USA) slides and kept at - 20ºC until 
used. 
Hybridization probes 
Different oligonucleotides complementary to the mRNA coding for monkey D2 and D4 
receptors were used: three oligonucleotides for D2 mRNA complementary to bases 52-
101, 1315-1365, and 1355-1400 (GenBank accession number M29066); two 
oligonucleotides for D4 mRNA, complementary to bases 66-113 and 1093-1135 
(GenBank accession number NM_000797). Each region was chosen because it shares 
no similarity with the other dopamine receptor subtypes. The results shown here for 
each receptor subtype were obtained by simultaneously using all the radioactively 
labeled oligonucleotides for the corresponding receptor as hybridization probes. 
Glutamatergic cells were identified by the vesicular glutamate transporter vGluT1 
mRNA with two oligonucleotides complementary to bases 26-67 and 1626-1670 
(GenBank acc no NM_020309). GABAergic cells were identified by the GABA 
synthesizing enzyme, glutamic acid decarboxylase (GAD), which in adult brain has two 
major isoforms, GAD65 and GAD67. Three oligonucleotides for each mRNA isoform 
were made: bases 237-281, 496-540 and 736-780 (M81882) and bases 811-855, 1059-
1103 and 2267-2311 (M81883). PV cells were identified by hybridization with 
oligonucleotides complementary to: 19-63, 70-111, 173-215, 335-379 bp of human PV 
mRNA (X63070). CB cells were identified by hybridization with oligonucleotides 
complementary to: 183-227, 448-492, 512-556, 809-853, 887-931, 938-982 bp of 
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human CB mRNA (NM_004929). All the oligonucleotides were synthesized and HPLC 
purified by Isogen Bioscience BV (Maarsden, The Netherlands).  
Each dopamine receptor oligonucleotide was individually labeled at its 3’-end with 
terminal deoxynucleotidyltransferase (TdT, Oncogene Research Products, San Diego, CA, 
USA) and [
33
P -dATP (3000 Ci mmol-1, New England Nuclear, Boston, MA, USA). 
Labeled probes were purified through ProbeQuant G-50 microcolumns (GE Healthcare, 
Little Chalfont, UK). All GAD, vGluT1, PV and CB oligonucleotides (100 pmol) were 
individually labeled with TdT and Dig-11-dUTP (Boehringer Mannheim, Germany), in 
line with a procedure described elsewhere (Schmitz et al., 1991). 
In situ hybridization histochemistry 
The protocols for single- and double-label in situ hybridization histochemistry were 
based on previously described procedures (Tomiyama et al., 1997; Landry et al., 2000) 
and have already been published (Serrats et al., 2003). Frozen tissues were brought to 
room temperature (22 ± 2 ºC), air-dried and fixed for 20 min in 4% paraformaldehyde in 
phosphate-buffered saline (PBS: 2.6 mM KCl, 1.4 mM KH2PO4, 136 mM NaCl, 8 mM 
Na2HPO4). They were then washed once in 3xPBS, twice in 1xPBS, 5 min each, and 
incubated in a freshly prepared solution of predigested pronase (incubated at 37ºC, 4 hr, 
and kept frozen in aliquots) (Calbiochem, San Diego, CA, USA) at a final concentration 
of 12 U/mL in 50 mM Tris-HCl pH 7.5 and 5 mM EDTA for 2 min at room temperature 
(22 ± 2 ºC). Proteolytic activity was stopped by immersion for 30 sec in 2 mg/mL glycine 
in PBS. Tissues were rinsed in PBS and dehydrated in 70% and 100% ethanol for 2 min 
each. For hybridization, the radioactive and non-radioactive labeled probes were 
appropriately combined and diluted in hybridization buffer (50% formamide, 4xSSC, 1x 
Denhardt’s solution, 1% sarkosyl, 10% dextran sulfate, 20 mM phosphate buffer, pH 7, 
250 g /mL yeast tRNA and 500 g/mL salmon sperm DNA) at approximately 1-2 x 
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10
4
cpm/L. For single in situ hybridization, all the oligonucleotides used were 
independently labeled with radioactivity (a total of 4 different oligonucleotides for 
dopamine receptor mRNA, 2 oligonucleotides for vGluT1 mRNA and 1 each for GAD65 
and GAD67 mRNA). For the double in situ hybridization experiments, all dopamine 
receptor probes (labeled with 
33
P) and all available probes for vGluT1, GAD65/67, PV or 
CB (labeled with digoxigenin) were combined and diluted to a final concentration of 
approximately 2 nM. Tissues were covered with 100L of the hybridization solution and 
overlaid with Nescofilm (Bando Chemical Ind, Kobe, Japan) coverslips to prevent 
evaporation. Tissues were incubated in humid boxes overnight at 42ºC and then washed 4 
times (45 min each) in 600 mM NaCl, 10 mM Tris-HCl, pH 7.5, and 1 mM EDTA at 
60ºC. Hybridized sections were exposed to Biomax-MR (Kodak, Rochester, NY, USA) 
films for 3-5 weeks at - 70ºC with intensifying screens. 
Development of radioactive and non-radioactive hybridization signal 
After washing, double in situ hybridized sections were immersed for 30 min in a 
buffer containing 0.1 M Tris-HCl pH 7.5, 1 M NaCl, 2 mM MgCl2 and 0.5% bovine 
serum albumin (Sigma) and incubated overnight at 4ºC in the same solution with 
alkaline-phosphate-conjugated anti-digoxigenin-F(ab) fragments (1:5000; Boehringer 
Mannheim). Afterwards, they were washed three times (10 min each) in the same buffer 
(without antibody), and twice in an alkaline buffer containing 0.1 M Tris-HCl pH 9.5, 
0.1 M NaCl and 5 mM MgCl2. Alkaline phosphatase activity was developed by 
incubating the sections with 3.3 mg nitroblue tetrazolium and 1.65 mg 
bromochloroindolyl phosphate (Gibco BRL, Gaithersburg, MD, USA) diluted in 10 mL 
of alkaline buffer. The enzymatic reaction was blocked by extensive rinsing in the 
alkaline buffer containing 1 mM EDTA. The sections were then briefly dipped in 70% 
and 100% ethanol, air-dried and dipped into Ilford K5 nuclear emulsion (Ilford, 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
9 
 
Mobberly, Cheshire, UK) diluted 1:1 with distilled water. They were exposed in the 
dark at 4°C for 6 weeks, developed in Kodak D19 (Kodak) for 5 min, and fixed in Ilford 
Hypam fixer (Ilford). 
Specificity of the probes 
The specificity of the autoradiographic signal obtained in the in situ hybridization 
histochemistry experiments was confirmed by performing a series of routine controls 
(Pompeiano et al., 1992). Briefly, for each mRNA under study, several oligonucleotide 
probes complementary to different regions of the same mRNA were used independently 
as hybridization probes in consecutive tissue sections showing identical pattern 
hybridization. For a given oligonucleotide probe, addition to the hybridization solution 
of an excess of the same unlabeled oligonucleotide resulted in the complete abolition of 
the specific hybridization signal. The remaining autoradiographic signal was considered 
background. If the unlabeled oligonucleotide included in the hybridization was a 
different oligonucleotide, then the hybridization signal was not affected (data not 
shown). The thermal stability of the hybrids was examined by washing at increasing 
temperatures: a sharp decrease in the hybridization signal was observed at a temperature 
consistent with the Tm of the hybrids. To confirm the specificity of the non-radioactive 
hybridization signal, we compared the results obtained with the same probe labeled 
radioactively (data not shown). 
Analysis of results 
Tissue sections were examined and cells quantified with an Olympus BX51 Stereo 
Microscope (Olympus, Tokyo, Japan). Visiopharm Integrator System software 
(Olympus) was used to draw contours around the zone of interest at low magnification. 
We used the optical dissector of the software to randomly sample cells in the region of 
interest with a 100x oil immersion objective. 
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Glutamatergic, GAD-positive, PV and CB cells were identified as cellular profiles 
exhibiting a dark precipitate (alkaline phosphatase reaction product) surrounding or 
covering the nucleus. Dopamine receptor mRNA hybridization signal was considered 
positive when accumulation of silver grains over the stained cellular profiles was greater 
than four times that of the background. Cells were counted using Visiopharm Integrator 
System software. 
Cell counting for dorsolateral PFC (DLPFC) was performed in areas 9 and 46, and 
for orbitofrontal cortex (OFC) in area 11; see Figure 1. Quantification was performed in 
layer V, where both types of dopamine receptor mRNA is consistently present. The 
percentage of cells expressing dopamine receptors was determined from an average of 
40.2 cells per cortical layer from each area and each case examined, with a total of 1931 
cells counted. Cortical layer V was identified in cresyl violet-stained sections.Analysis 
of variance (ANOVA) and Bonferroni post-tests were performed using GraphPad Prism 
software (GraphPad Software, San Diego, CA). P < 0.05 was considered statistically 
significant.  
Preparation of figures 
Photographs of the film autoradiograms of the hybridized tissue sections were taken 
with a Wild 420 Leica macroscope equipped with a digital camera (DXM1200 F, 
Nikon, Tokyo, Japan) and ACT-1 Nikon Software. Microphotography of the hybridized 
tissue slides was performed using a Nikon Eclipse E1000 microscope equipped with a 
digital camera (DXM1200, Nikon) and analySIS Software (Soft Imaging System, 
Münster, Germany). Figures were prepared for publication using Adobe Photoshop 
software (Adobe Software, San Jose, CA, USA). The contrast and brightness of the 
images were the only variables we adjusted digitally. 
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Results  
Distribution of D2 and D4 receptor mRNA in glutamatergic and GABAergic 
cortical neurons 
Previous studies have described the presence of D2 and D4 receptor mRNA mainly in 
layer V of primate PFC (Lidow et al., 1998), and in both glutamatergic and GABAergic 
neurons (2001; Khan et al., 1998; Paspalas and Goldman-Rakic, 2004). In good 
agreement with these findings, we found that D2 receptor is mainly expressed in layer V 
cells, whereas D4 receptor is expressed in all layers of the PFC except layer I, and its 
highest levels are in layer V (Fig. 1). As expected, D2 (Fig. 2a, 2c) and D4 (Fig. 2b, 2d) 
receptor mRNAs co-localized with the cellular markers vGluT1 (Fig. 2a, 2b) and GAD 
65/67 (Fig. 2c, 2d). D2 receptor mRNA is expressed in about 55% of glutamatergic 
neurons and in about 35% of GAD-positive interneurons. The presence of D4 receptor 
was significantly higher than that of D2 receptor in both neuronal populations (p<0.05). 
About 75% of glutamate neurons and nearly half of the GAD-positive interneurons 
express D4 receptor (Fig. 4). Thus, the data extends previous findings by showing a 
more widespread distribution of D4 receptors than D2 receptors both in pyramidal 
neurons and GABAergic interneurons across the monkey dorsolateral PFC and OFC. 
D2 and D4 receptor expression in PFC interneurons 
A few reports based on immunohistochemistry describe the presence of D2 receptor 
and D4 receptors in primate PFC PV+ interneurons (Khan et al., 2001; Mrzljak et al., 
1996). However, and despite the relevance of PV+ and CB+ interneuron subpopulations 
in schizophrenia, bipolar disorder and depression, there are no quantitative studies 
assessing the relative abundance of D2 and D4 receptors in PV+ and CB+ interneurons. 
Here we quantified D2 and D4 mRNA expression in layer V, where both types of 
dopamine receptor mRNA are consistently present. 
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Double in situ hybridization shows that CB and PV mRNAs can co-localize with D2 
and D4 mRNAs (Fig. 3). Both D2 and D4 receptors were expressed in 40% of CB+ 
neurons. However, a high proportion of PV+ neurons expressed D4 receptor (65-66%) 
and a relatively low percentage expressed D2 (15-20%) (Fig. 4). There were no 
significant differences between OFC and DLPFC in any of the cases studied (Fig. 4). 
Thus, there is a heterogeneous distribution of dopamine receptors in cortical interneuron 
populations, where PV+ interneurons are enriched in D4 receptors. 
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Discussion  
The present work establishes the expression of D2 and D4 receptor mRNA in 
different cellular populations of monkey PFC. Our main findings are: 1) D4 receptor 
mRNA has a more widespread laminar distribution than D2 receptor, which is 
expressed almost exclusively in neurons in layer V; 2) both receptors are expressed in a 
large percentage of glutamatergic and GAD-positive neurons in layer V, but D4 
receptor is present in a greater proportion of both neuronal populations than is D2 
receptor; 3) most (about 65%) PV+ perisomal interneurons express D4 receptors while 
only a minority (15-20%) express D2 receptors.  
Schizophrenia and the distribution of D2 and D4 receptors in the PFC  
Irregularities in PFC inhibitory neurotransmission in schizophrenia, bipolar disorder 
and major depressive disorder seem to be mostly restricted to alterations in two 
subpopulations of GABAergic neurons; CB and PV interneurons (Daviss and Lewis, 
1995; Rajkowska et al., 2007; Sakai et al., 2008; Hashimoto et al., 2003; Beasley et al., 
2002). The most recent hypotheses on the pathophysiology of schizophrenia suggest 
that there is a hypofunction of the chandelier cells (PV+ GABAergic interneurons) due 
to a hypofunction of NMDA receptors (see (Lewis and Gonzalez-Burgos, 2006; Lisman 
et al., 2008) for a review). In primate PFC, these perisomal interneurons are activated by 
axon collaterals of pyramidal neurons, and they provide a potent inhibitory feedback by 
acting over the axon cone (Melchitzky and Lewis, 2003). The model suggests that a 
functional deficit of PV+ interneurons would diminish the effectiveness of the inhibiting 
loop, resulting in disinhibition of the pyramidal neurons. In this way, the functional 
deficit of PV+ interneurons causes hyperactivity in basal conditions, saturating the 
capacity of pyramidal neurons and preventing normal recruitment of the PFC and 
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hippocampus during cognitive tasks (Lewis et al., 2005). Our results show that when 
analyzing the population of GABAergic interneurons as a whole, the proportion of 
interneurons expressing D2 receptor (35%) did not differ greatly from the proportion of 
those expressing D4 receptor (47%) (Fig. 4). Nevertheless, when considering only the 
perisomal PV+ interneurons, the majority of them (65%) express D4 receptors, while 
and only 15-20% express D2 receptors. Because of the predominance of D4 receptor in 
parvalbumin interneurons, we hypothesived that D4 receptor could be a complementary 
target in designing new antipsychotics. The effect of those antipsychotics could be the 
inhibition of the activity of the inhibitory D4 receptors located in the inhibitory PV+ 
interneurons. This would increase the activity of PV cells and thereby diminish 
pyramidal neuron hyperactivity. 
D4 activation has been shown to hamper synaptic excitation in GABAergic 
interneurons that would lead to decreased GABAergic inhibition in the PFC circuit 
(Yuen and Yan, 2009). Moreover, the main problem with classic antipsychotics are 
extra-pyramidal effects, partly as a result of the occupation of D2 receptors located in 
the caudate-putamen nuclei. Studies to determine the presence and densities of D4 
receptors in the striatum have produced controversial results (from high to very low 
levels) by using either immunohistochemistry with different antibodies (Defagot et al., 
1997; Mauger et al., 1998; Rivera et al., 2002; Mrzljak et al., 1996; Ariano et al., 1997), 
or receptor autoradiography (Defagot et al., 2000; Defagot and Antonelli, 1997; De La 
and Madras, 2000; Primus et al., 1997; Murray et al., 1995). In situ hybridization 
describes D4 mRNA levels in the caudate-putamen as ranging from low to very low 
(Lidow et al., 1998) (de Almeida and Mengod, unpublished observations). This is 
consistent with the low to very low levels resulting from rat and human RT-PCR 
experiments (Suzuki et al., 1995; Van Tol et al., 1991; Matsumoto et al., 1995; 
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Matsumoto et al., 1996), and also with single-cell RT-PCR from human striatal neurons 
(Surmeier et al., 1996). All this indicates that the presence of D4 receptors in the 
striatum is still a subject of debate, but if there are indeed there, it is in much smaller 
quantities than D2 receptors. This suggests that the replacement of part of D2 
antagonism by D4 antagonism in the development of antipsychotics could reduce the 
unwanted side effects of these drugs.  
In conclusion, both D2 and D4 receptors are found in different neuronal populations 
in the PFC of primates. D4 receptor is more ubiquitous in both laminar and cellular 
distributions. This is important when assessing the performance of these receptors in the 
dopaminergic modulation of the PFC through receptors from the D2 family, and also 
their link with schizophrenia and its therapies. For a better understanding of dopamine 
modulation in the PFC, D1-like dopamine receptors should also be studied in different 
neural populations. Knowledge of the differential distribution of dopamine receptors in 
pyramidal neurons and interneurons in primate PFC could elucidate the specific 
functional contribution of each receptor to inherent PFC functions, such as working 
memory. Furthermore, this knowledge could pinpoint the role of alterations in the 
abundance of these receptors or in their cellular location on diseases such as Parkinson’s 
or schizophrenia. 
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Figure Legends 
Figure 1. Autoradiographic localization of dopamine D2 (A) and D4 (B) receptor 
mRNA in monkey prefrontal cortex. Both mRNA transcripts were visualized by in situ 
hybridization with oligonucleotides labeled with 
33
P. Panel A shows the areas where 
cells were quantified. (DLPFC: dorsolateral prefrontal cortex, OFC: orbitofrontal 
cortex). Bar: 5 mm. 
Figure 2. Localization of D2 and D4 receptor mRNA in glutamatergic and 
GABAergic cells in primate prefrontal cortex. High-magnification, bright-field 
microphotographs of emulsion-dipped sections simultaneously showing by double in 
situ hybridization the presence of D2 (a, c) and D4 (b, d) dopamine receptor mRNA in 
glutamatergic (a, b) and GABAergic (c, d) layer V neurons of monkey prefrontal cortex. 
The oligonucleotides complementary to the receptor mRNA were radiolabeled and are 
observed as clusters of dark silver grains. The oligonucleotides complementary to the 
mRNA of the glutamatergic marker vGluT1 and GABAergic marker GAD65/67 were 
labeled with digoxigenin and are observed as heavily purple stained cells. Bar: 20 μm. 
Figure 3. Localization of D2 and D4 receptors mRNA in parvalbumin (PV)  and 
calbindin (CB) cell populations in monkey prefrontal cortex. High-magnification bright-
field microphotographs of emulsion-dipped sections of layer V monkey dorsolateral 
prefrontal cortex, simultaneously showing the different mRNA visualized by double in 
situ hybridization using 
33
P-labeled oligonucleotides complementary to the mRNA 
coding for D2 (a, c) and D4 (b, d) dopamine receptors (clusters of dark silver grains), 
with DIG-labeled oligonucleotides (dark precipitate) for PV mRNA, panels a and b, or 
for CB mRNA, panels c and d. Bar: 20 µm. 
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Figure 4. Bar graph showing the distribution of D2 and D4 dopamine receptors in 
different neuronal populations of primate prefrontal cortex (vGluT1: vesicular 
glutamate transporter, GAD: gamma-aminobutiric acid decarboxylase, PV: 
parvalbumin, CB: calbindin, DLPFC: dorsolateral prefrontal cortex, OFC: orbitofrontal 
cortex). Data are the mean and SEM of three monkeys and represent the percentage of 
counted cells expressing D2 and D4 dopamine receptor mRNA in different neuronal 
populations. Each percentage was determined from an average of 40.2 cells (1931 cells 
counted). 
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